ro glp 1 stock SERENA WILLIAMS JOINS AS GLP-1 CELEBRITY AMBASSADOR “I can make it to

When theyre not, even loyal shoppers may hesitate or choose another option simply because it feels easier

Allison Whitten AstraZeneca reports mixed Phase 3 results across oncology and rare disease AstraZeneca reported mixed late-stage clinical results, with its Claudin 18.2-targeting antibody-drug conjugate sonesitatug vedotin meeting its primary endpoint in patients with previously treated advanced gastric cancer, while rare disease therapy Ultomiris missed the primary endpoint in a Phase 3 trial for thrombotic microangiopathy following haematopoietic stem cell transplantation (HSCT-TMA)

Injections can be administered up to twice a week

The effect of L-acetylcarnitine on some reproductive functions in the oligoasthenospermic rat

These approvals provide a useful regulatory framework and signal the direction of travel for future agents such as retatrutide